#None #digital health #CES Innovation #exoRehab

EXOSYSTEMS' exoRehab: A Revolutionary Solution in Digital Health

EXOSYSTEMS Inc. has made a remarkable leap in the field of digital health by receiving an accolade at CES 2026 for its innovative product, exoRehab. This recognition as a CES Innovation Awards honoree underscores the product's potential to transform traditional rehabilitation practices for musculoskeletal care.

What is exoRehab?

exoRehab is a state-of-the-art Remote Therapeutic Monitoring (RTM) solution designed to facilitate recovery from various musculoskeletal issues. With a combination of a user-friendly mobile application and a complimentary web-based dashboard, this advanced technology allows patients to engage in rehabilitation exercises from the comfort of their homes. The system employs a lightweight, skin-safe wearable device that tracks muscle activity and movement in real-time, providing valuable insight into the patient’s recovery journey.

How Does It Work?

At the heart of exoRehab is its ability to connect patients and healthcare professionals seamlessly. The wearable device collects data on muscle engagement (through surface EMG) and dynamic movements (using Inertial Measurement Units - IMU) and shares this information through the app and dashboard. EXOSYSTEMS has developed what is known as the Muscle Function Index (MFI), which serves as a proprietary neuromuscular digital biomarker. This innovative metric transforms raw data into understandable scores allowing both patients and providers to monitor improvements and adverse trends effectively.

The Benefits of exoRehab

• - For Patients: exoRehab offers clarity in home exercise instructions, timely feedback, reduced necessity for clinic visits, and overall accelerated recovery times. Patients can maintain a consistent rehabilitation program without the stress of travel.
• - For Clinicians and Therapists: The platform presents objective data regarding muscle function and movement, enabling early detection of potential issues like stiffness or weakness. This consistent, high-quality information supports effective documentation of patient progress, thereby streamlining clinic workflows.
• - For Health Systems and Researchers: exoRehab delivers robust data that standardizes evaluation processes, allowing systems to improve care quality and validate what therapeutic approaches work effectively.

Designed for Modern Healthcare Workflows

exoRehab aligns with existing U.S. healthcare pathways for Remote Therapeutic Monitoring (RTM), adhering to CPT code standards. This compliance enhances its usability among clinics, allowing healthcare teams to efficiently track patient adherence and therapeutic activities while simplifying documentation procedures necessary for reimbursement.

Live Demonstration at CES 2026

EXOSYSTEMS plans an engaging showcase at CES 2026, where attendees can experience exoRehab first-hand. The presentation will feature live demos, illustrating the wearable’s operation, real-time muscle tracking displayed in the app, and a guided home exercise routine. These demonstrations aim to provide a tangible understanding of how exoRehab intricately bolsters the rehabilitation experience.

Insights from the Executive Team

CEO Hooman Lee emphasized the vision behind exoRehab, stating, “We designed exoRehab so people can see their recovery, not just feel it.” This commitment to delivering objective muscle signals embodies the company's goal of transforming rehabilitation from a passive experience into an interactive journey filled with daily achievements that patients and clinicians can equally monitor.

About EXOSYSTEMS

Founded in 2017, EXOSYSTEMS is at the forefront of medical AI innovation focused on developing neuromuscular digital biomarkers and personalized therapeutic solutions. Its Muscle Function Index (MFI) has garnered recognition, being peer-reviewed and designated as an innovative medical device by Korea’s MFDS, affirming its clinical significance in diagnosing conditions like sarcopenia.

The impending launch of exoRehab is set to provide patients with personalized rehabilitation programs, utilizing wearables for effective muscle stimulation across various body regions. Notably, the positive therapeutic impacts of EXOSYSTEMS' digital interventions have been documented in distinguished publications such as the Journal of the American Medical Directors Association (JAMDA).

To conclude, EXOSYSTEMS stands as a pioneering force in revolutionizing rehabilitation, and exoRehab's recognition at CES 2026 serves as a testament to the future of digital health solutions.